The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs
Abstract
Poorly soluble drugs constitute more than 60% of currently marketed pharmaceuticals with over two‐thirds of promising new chemical entities failing to enter a clinical setting due to solubility issues. Although oral formulations have made some impact, alternative enhancement strategies for administration of such molecules are actively sought. Over the last decade, innovation on a global scale has enabled the expansion of the frontiers of microarray patches (MAPs) further than ever before. Initially designed to load low doses of hydrophilic and potent therapeutic agents, MAPs are now becoming a viable strategy for the immediate and long‐acting delivery of poorly soluble drugs through the skin. This together with the advantages of transdermal administration over the oral and parenteral routes, make of MAPs an appealing platform for the development of products with increased patient compliance. Undoubtedly, MAPs will soon become a readily available therapeutic alternative, and experts from academia, industry and regulatory bodies are working together aiming to facilitate the progression of MAPs toward safe and effective clinical use. This review aims to highlight the ability of MAPs to deliver poorly soluble actives, discuss the mechanisms behind in‐skin drug absorption, and evaluate the future direction of the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Applying this technology to deliver MNC topically reduces the systemic exposure and bacterial resistance without affecting the normal flora in the gastrointestinal tract. Also, avoids the problematic adverse effects of this drug and enhances the bioavailability due to eliminating the first pass metabolism [27,28,29,30].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [27]
In the citing paper
“PLGA MNs demonstrated their ability to encapsulate therapeutics while having sufficient mechanical properties to penetrate the stratum corneum for efficient delivery [27].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Silicon micromachined hollow microneedles for transdermal liquid transport
Gardeniers, H. J. G. E., Luttge, R., Berenschot, E. J. W., de Boer, M. J., Yeshurun, S. Y., Hefetz, M., van-t Oever, R., & van den Berg, A. (2003) · Journal of Microelectromechanical Systems · doi:10.1109/jmems.2003.820293 · Cited by 413
Research works printed but not linked: 183
- 10.1016/S1056-8719(00)00107-6 · DOI · Paper page
- Martin A. N., 1993, Physical Pharmacy : Physical Chemical Principles in the Pharmaceutical Sciences
- 10.1016/j.ijpharm.2008.04.042 · DOI · Paper page
- 10.1517/17425247.2013.860130 · DOI · Paper page
- 10.4172/2157-7439.1000125 · DOI
- 10.1016/j.ijpx.2020.100050 · DOI
- 10.1038/nbt.1504 · DOI · Paper page
- 10.1038/nrd1304 · DOI · Paper page
- 10.2174/156720106775197457 · doi:10.2174/156720106775197457
- Williams A. C., 2012, Adv. Drug Delivery Rev., 24, 3
- Ning X., 2019, Imaging Technologies and Transdermal Delivery in Skin Disorders
- 10.1080/17425247.2020.1713087 · DOI · Paper page
- 10.1007/s11095-010-0169-8 · DOI · Paper page
- 10.1016/j.drudis.2017.10.013 · DOI
- 10.1371/journal.pone.0111547 · DOI
- 10.1016/j.mser.2016.03.001 · DOI · Paper page
- Gerstel M. S., 1976, Drug Delivery Device
- 10.1002/9781119959687 · DOI · Paper page
- 10.1016/j.addr.2012.04.005 · DOI · Paper page
- 10.1021/js980042 · doi:10.1021/js980042
- 10.1016/S0168-3659(04)00171-3 · doi:10.1016/s0168-3659(04)00171-3 · Paper page
- 10.1023/B:PHAM.0000029282.44140.2e · DOI · Paper page
- 10.1007/s13346-015-0243-1 · DOI
- 10.1023/A:1013395102049 · doi:10.1023/a:1013395102049
- 10.1111/j.1365-2133.2004.05921.x · DOI
- 10.1517/17425247.2012.676038 · DOI
- 10.3390/pharmaceutics6020220 · DOI
- 10.1007/s11095-014-1301-y · doi:10.1007/s11095-014-1301-y
- 10.1016/j.addr.2003.10.023 · DOI · Paper page
- 10.1016/j.ijpharm.2010.03.041 · DOI
- 10.1007/s11095-010-0227-2 · DOI
- 10.1186/2050-6511-13-5 · DOI
- 10.1002/adfm.201200864 · DOI · Paper page
- 10.1016/j.jconrel.2006.10.017 · DOI · Paper page
- 10.1016/j.ijpharm.2011.11.046 · DOI
- 10.1007/s11095-010-0192-9 · DOI · Paper page
- 10.3109/10717541003667798 · DOI · Paper page
- 10.1016/j.biomaterials.2007.12.048 · DOI · Paper page
- 10.1016/j.ejpb.2012.07.008 · DOI
- 10.1248/bpb.33.683 · DOI
- 10.1007/s11095-011-0419-4 · doi:10.1007/s11095-011-0419-4
- 10.1002/smll.201001091 · DOI · Paper page
- 10.1016/j.ijpharm.2012.05.069 · DOI
- 10.1007/s11095-005-8498-8 · DOI · Paper page
- 10.1109/JMEMS.2014.2307320 · DOI
- 10.1007/s10544-012-9717-9 · DOI
- 10.1109/TBME.2019.2906571 · doi:10.1109/tbme.2019.2906571
- 10.1016/j.sna.2009.01.020 · DOI
- 10.1109/TBME.2007.906492 · DOI
- 10.1038/sj.jid.5700150 · DOI · Paper page
- 10.1007/s10404-009-0467-9 · DOI
- 10.1016/j.jconrel.2018.12.026 · DOI · Paper page
- 10.1016/j.ijpharm.2018.06.001 · doi:10.1016/j.ijpharm.2018.06.001
- 10.1109/TBME.2005.845240 · DOI · Paper page
- 10.1111/pedi.12031 · DOI
- 10.1080/10717544.2018.1455760 · doi:10.1080/10717544.2018.1455760
- 10.1007/s11095-017-2261-9 · doi:10.1007/s11095-017-2261-9
- 10.1038/srep29075 · DOI
- 10.1016/j.ijpharm.2018.06.002 · DOI
- 10.1016/j.bios.2014.11.010 · DOI
- 10.1038/srep29075 · DOI
- 10.1016/S2589-7500(19)30131-1 · DOI · Paper page
- 10.1002/adfm.201909197 · DOI · Paper page
- 10.1002/adhm.201500450 · DOI · Paper page
- 10.1016/j.sbsr.2020.100348 · DOI · Paper page
- 10.1002/advs.201902872 · DOI
- 10.1016/j.biopha.2018.10.078 · DOI · Paper page
- 10.1002/jin2.41 · DOI
- 10.3390/pharmaceutics11070308 · DOI
- 10.3390/pharmaceutics11070346 · DOI
- 10.1016/j.jconrel.2018.11.002 · DOI
- 10.1002/adhm.201801510 · DOI
- 10.1016/j.xphs.2019.11.012 · DOI
- 10.1016/j.ejpb.2020.06.025 · DOI · Paper page
- 10.1016/j.jconrel.2008.04.019 · DOI · Paper page
- 10.1016/j.apsb.2015.09.006 · doi:10.1016/j.apsb.2015.09.006
- Lee S. G., 2013, Int. J. Nanomed., 9, 289
- 10.1016/j.ijpharm.2019.118741 · DOI
- 10.1016/j.jconrel.2019.10.004 · DOI · Paper page
- 10.1016/j.pdpdt.2010.09.001 · DOI
- 10.1111/jphp.12118 · DOI
- 10.1016/j.jconrel.2015.12.038 · DOI
- 10.1016/j.jconrel.2015.10.026 · doi:10.1016/j.jconrel.2015.10.026
- 10.1016/j.jconrel.2017.10.005 · DOI · Paper page
- 10.1016/j.ijpharm.2014.06.010 · doi:10.1016/j.ijpharm.2014.06.010
- 10.1007/s11095-013-1240-z · DOI
- 10.1002/jps.24159 · DOI
- 10.1016/j.ijpharm.2011.01.039 · DOI
- 10.1002/jps.24563 · DOI
- 10.1039/C4TB00764F · DOI
- 10.1116/1.4913378 · doi:10.1116/1.4913378
- 10.1116/1.4941448 · DOI
- 10.1016/j.mattod.2014.04.027 · DOI · Paper page
- 10.1007/s11837-013-0574-7 · DOI
- H. S.Gill M. R.Prausnitz 2007 24 1369. · DOI · Paper page
- Date N. B., 2014, Int. J. Res. Rev. Pharm. Appl. Sci., 4, 1083
- 10.1016/j.jconrel.2017.03.015 · DOI
- 10.1016/j.ejpb.2018.02.014 · doi:10.1016/j.ejpb.2018.02.014
- 10.1016/j.jconrel.2019.11.002 · DOI
- 10.1038/s41551-018-0337-4 · DOI · Paper page
- Li W., 2019, Sci. Adv., 5, eaaw814
- 10.1016/j.xphs.2017.11.013 · DOI
- 10.1016/j.xphs.2020.02.009 · DOI
- 10.3390/pharmaceutics11110605 · DOI
- So J. W., 2009, Drug Delivery
- 10.1016/j.ijpharm.2017.10.035 · DOI
- 10.1016/j.jconrel.2019.05.038 · DOI · Paper page
- 10.1016/j.nano.2011.05.016 · DOI · Paper page
- 10.1016/j.addr.2011.01.012 · DOI · Paper page
- 10.1016/j.yexmp.2008.12.004 · DOI · Paper page
- 10.1533/9781908818195 · doi:10.1533/9781908818195
- 10.1016/j.ejpb.2011.01.007 · DOI · Paper page
- 10.3390/pharmaceutics10030134 · DOI · Paper page
- 10.1016/j.powtec.2016.07.026 · DOI
- 10.1038/nrd1494 · DOI · Paper page
- 10.1016/j.ijpharm.2008.07.023 · DOI · Paper page
- 10.1016/j.ijpharm.2010.07.044 · DOI · Paper page
- 10.1016/j.ijpharm.2012.09.034 · DOI · Paper page
- 10.1016/j.jddst.2016.02.006 · DOI
- 10.1016/j.drudis.2018.01.016 · DOI · Paper page
- 10.1016/j.ejps.2013.09.002 · doi:10.1016/j.ejps.2013.09.002
- 10.1016/j.ejpb.2012.01.005 · DOI
- 10.1016/j.ijpharm.2020.119501 · DOI
- 10.1016/j.powtec.2020.06.025 · doi:10.1016/j.powtec.2020.06.025
- M. E.Melian A.Paredes B.Munguía M.Colobbio J. C.Ramos R.Teixeira E.Manta S.Palma R.Faccio L.Domínguez 2020 21 1. · doi:10.1208/s12249-020-01777-y
- 10.1016/j.ejpb.2005.05.009 · DOI · Paper page
- 10.1016/j.ijpharm.2019.02.045 · DOI · Paper page
- 10.1177/0148607181005003230 · DOI
- 10.1016/j.ejpb.2013.08.013 · DOI · Paper page
- 10.1016/S0939-6411(00)00087-4 · DOI · Paper page
- Karunanidhi P., 2012, Sci. Rev. Chem. Commun., 2, 80
- 10.1016/j.ejps.2017.11.023 · DOI · Paper page
- 10.1016/j.ijpharm.2008.10.003 · DOI · Paper page
- Joshi S. A R. K., 2012, IOSR J. Pharm., 2, 34
- 10.1016/j.dib.2015.11.038 · doi:10.1016/j.dib.2015.11.038
- 10.15171/apb.2015.043 · DOI · Paper page
- 10.1016/j.ijpharm.2009.03.013 · DOI
- 10.1038/1921197a0 · DOI · Paper page
- 10.2174/157341311795542453 · DOI · Paper page
- Mozafari M. R., 2005, Cell. Mol. Biol. Lett., 10, 711
- 10.1007/s11095-008-9800-3 · DOI · Paper page
- 10.1016/j.colsurfb.2009.09.001 · DOI · Paper page
- Kumar M. S. B. P., 2014, Indian J. Pharm. Sci. Res., 4, 102
- 10.1016/j.bjp.2015.03.010 · doi:10.1016/j.bjp.2015.03.010
- 10.1016/j.ijbiomac.2018.01.085 · DOI
- 10.1111/1750-3841.13951 · doi:10.1111/1750-3841.13951
- 10.1016/B978-0-08-102548-2.00004-4 · DOI
- 10.3390/vaccines6030060 · DOI
- 10.1002/btm2.10103 · DOI
- 10.1007/s11095-006-0028-9 · DOI · Paper page
- 10.3389/fbioe.2019.00296 · DOI
- 10.1021/acsami.9b22425 · DOI
- 10.1016/j.drudis.2019.11.001 · DOI
- 10.1016/j.jconrel.2005.02.002 · DOI · Paper page
- 10.1016/j.apsb.2013.11.001 · DOI · Paper page
- 10.3390/pharmaceutics11030132 · DOI
- 10.1124/jpet.119.258707 · DOI
- 10.1002/jps.24159 · DOI
- 10.1166/jbn.2017.2474 · DOI · Paper page
- 10.2147/CCID.S10182 · DOI
- 10.1080/13697130500148875 · DOI · Paper page
- 10.1080/10837450802498894 · doi:10.1080/10837450802498894
- 10.1016/S0378-5173(02)00334-4 · doi:10.1016/s0378-5173(02)00334-4
- 10.1016/j.ijpharm.2017.08.087 · doi:10.1016/j.ijpharm.2017.08.087
- 10.1007/s12039-019-1666-x · DOI
- 10.1208/s12249-019-1560-3 · DOI
- 10.1016/j.ijpharm.2008.11.029 · doi:10.1016/j.ijpharm.2008.11.029
- 10.1021/ja02086a003 · DOI · Paper page
- 10.1111/jphp.12834 · DOI
- 10.1016/j.vetpar.2017.12.022 · DOI
- 10.4155/tde-2017-0090 · DOI
- 10.1016/j.yjmcc.2019.06.002 · DOI
- 10.1089/lrb.2008.1008 · DOI · Paper page
- 10.1038/s41578-019-0110-7 · DOI · Paper page
- 10.1021/acs.langmuir.8b02946 · DOI · Paper page
- Zhang X. Y., 2014, Cancer Biol. Med., 11, 247
- 10.1016/j.jconrel.2017.04.022 · DOI
- 10.1016/j.addr.2019.10.004 · DOI · Paper page
- 10.1097/COH.0000000000000293 · DOI · Paper page
- 10.1016/j.ijbiomac.2018.11.230 · DOI
- Chen Z., 2020, Drug Discovery Today, 25, 8
- 10.2217/nnm.12.214 · DOI
- World Health Organization, 2020, HIV/AIDS
Cited by
On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
Formica, M. L., Real, D. A., Picchio, M. L., Catlin, E., Donnelly, R. F., & Paredes, A. J. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101631 · Cited by 282
Self-citationMicroneedle array systems for long-acting drug delivery
Vora, L. K., Moffatt, K., Tekko, I. A., Paredes, A. J., Volpe-Zanutto, F., Mishra, D., Peng, K., Raj Singh Thakur, R., & Donnelly, R. F. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.006 · Cited by 270
Self-citationAbu Ershaid, J. M., Abudoleh, S. M., Lafi, D. N., & Dahshan, N. A. (2025) · Polymers · doi:10.3390/polym17212912 · Cited by 5
Metadata
- Authors
- Paredes, A. J., McKenna, P. E., Ramöller, I. K., Naser, Y. A., Volpe‐Zanutto, F., Li, M., Abbate, M. T. A., Zhao, L., Zhang, C., Abu‐Ershaid, J. M., Dai, X., & Donnelly, R. F.
- Affiliations
- School of Pharmacy Queen's University Belfast Medical Biology Centre 97 Lisburn Road Belfast BT9 7BL UK
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-09-18
- Volume
- 31
- Issue
- 1
- ISSN
- 1616-301X
- 1616-3028
- Cited by
- 88
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs. https://app.cochat.ai/papers/10.1002/adfm.202005792
- The paper
- Paredes, A. J., McKenna, P. E., Ramöller, I. K., Naser, Y. A., Volpe‐Zanutto, F., Li, M., Abbate, M. T. A., Zhao, L., Zhang, C., Abu‐Ershaid, J. M., Dai, X., & Donnelly, R. F. (2021). Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs. Advanced Functional Materials. https://doi.org/10.1002/adfm.202005792
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.